Telmisartan + indapamide

Telmisartan + indapamide has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest story, Oct 30, 2026: “Triple blood pressure pill reached near-full effect in two weeks”.

Intervention

1 paper studies it2 more mention itUpdated

PubChemPubChemChEBIChEBI

3 new papers in 30 daysSee all 3

  • Human trial1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 33 papers in 12 months
ESC Congress 2026 Abstract

Triple blood pressure pill reached near-full effect in two weeks

In two randomized trials involving 3,299 adults with hypertension, a three-drug pill achieved virtually all its blood pressure reduction within two weeks.In two randomized trials involving 3,299 adults with hypertension, a three-drug pill achieved virtually all its blood pressure reduction within two weeks.

Randomized trial · 3,299 peopleInterventions
ESC Congress 2026 Abstract

Low-dose triple pill lowered blood pressure alone or added on

The pill lowered the upper blood pressure reading by 15 mmHg and the lower by 7 mmHg versus placebo at six weeks.The pill lowered the upper blood pressure reading by 15 mmHg and the lower by 7 mmHg versus placebo at six weeks.

Randomized trial · 1,670 peopleInterventions
ESC Congress 2026 Abstract

Three-drug pill reduced blood pressure swings after brain bleed

The spread of upper blood pressure readings, measured by standard deviation, was 2.05 mmHg lower with the pill than with placebo.The spread of upper blood pressure readings, measured by standard deviation, was 2.05 mmHg lower with the pill than with placebo.

Randomized trial · 1,557 peopleInterventions